NI201300063A - Método para el tratamiento de una infección - Google Patents
Método para el tratamiento de una infecciónInfo
- Publication number
- NI201300063A NI201300063A NI201300063A NI201300063A NI201300063A NI 201300063 A NI201300063 A NI 201300063A NI 201300063 A NI201300063 A NI 201300063A NI 201300063 A NI201300063 A NI 201300063A NI 201300063 A NI201300063 A NI 201300063A
- Authority
- NI
- Nicaragua
- Prior art keywords
- compound
- treatment
- antibiotic
- nsaid
- infection
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 3
- 239000003125 aqueous solvent Substances 0.000 abstract 2
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
- 210000005075 mammary gland Anatomy 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000002132 β-lactam antibiotic Substances 0.000 abstract 1
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ588686A NZ588686A (en) | 2011-01-20 | 2011-01-20 | Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI201300063A true NI201300063A (es) | 2014-05-23 |
Family
ID=46515931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI201300063A NI201300063A (es) | 2011-01-20 | 2013-07-17 | Método para el tratamiento de una infección |
Country Status (15)
| Country | Link |
|---|---|
| KR (1) | KR101905173B1 (zh) |
| CN (1) | CN103327984B (zh) |
| AU (1) | AU2012207698A1 (zh) |
| BR (1) | BR112013018557B1 (zh) |
| CL (1) | CL2013002086A1 (zh) |
| CO (1) | CO6801732A2 (zh) |
| CR (1) | CR20130401A (zh) |
| GT (1) | GT201300182A (zh) |
| IL (1) | IL227540A (zh) |
| MX (1) | MX353876B (zh) |
| NI (1) | NI201300063A (zh) |
| NZ (1) | NZ588686A (zh) |
| PE (1) | PE20140035A1 (zh) |
| WO (1) | WO2012099479A1 (zh) |
| ZA (1) | ZA201305780B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2995297A1 (fr) * | 2014-09-09 | 2016-03-16 | Ceva Sante Animale | Compositions parentérales et leurs utilisations |
| AR102172A1 (es) | 2015-10-05 | 2017-02-08 | Química Luar S R L | Una composición farmacéutica bactericida y virucida |
| CN105663037A (zh) * | 2016-01-27 | 2016-06-15 | 成都乾坤动物药业有限公司 | 一种阿莫西林溶液剂及其制备方法和用途 |
| CN112472667B (zh) * | 2019-08-23 | 2022-11-15 | 北京欧博方医药科技有限公司 | 一种维他昔布长效注射液及其制备方法和应用 |
| CN111035614B (zh) * | 2019-12-20 | 2024-02-02 | 北京喜禽药业有限公司 | 一种高含量土霉素注射液及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6787568B1 (en) * | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
| CN1297319C (zh) * | 2003-09-22 | 2007-01-31 | 王玉万 | 以硅油为介质制备含抗微生物药物的制剂 |
| US20050148519A1 (en) | 2003-10-29 | 2005-07-07 | Murthy Yerramilli V.S. | Salts of pharmacologically active compounds |
| DE102004025324A1 (de) * | 2004-05-19 | 2005-12-08 | Boehringer Ingelheim Vetmedica Gmbh | Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung |
-
2011
- 2011-01-20 NZ NZ588686A patent/NZ588686A/xx unknown
-
2012
- 2012-01-20 PE PE2013001576A patent/PE20140035A1/es not_active Application Discontinuation
- 2012-01-20 CN CN201280005989.4A patent/CN103327984B/zh active Active
- 2012-01-20 WO PCT/NZ2012/000003 patent/WO2012099479A1/en active Application Filing
- 2012-01-20 AU AU2012207698A patent/AU2012207698A1/en not_active Abandoned
- 2012-01-20 KR KR1020137021988A patent/KR101905173B1/ko active IP Right Grant
- 2012-01-20 MX MX2013008407A patent/MX353876B/es active IP Right Grant
- 2012-01-20 BR BR112013018557-0A patent/BR112013018557B1/pt active IP Right Grant
-
2013
- 2013-07-17 GT GT201300182A patent/GT201300182A/es unknown
- 2013-07-17 NI NI201300063A patent/NI201300063A/es unknown
- 2013-07-18 IL IL227540A patent/IL227540A/en not_active IP Right Cessation
- 2013-07-19 CL CL2013002086A patent/CL2013002086A1/es unknown
- 2013-07-31 ZA ZA2013/05780A patent/ZA201305780B/en unknown
- 2013-08-05 CO CO13186092A patent/CO6801732A2/es unknown
- 2013-08-19 CR CR20130401A patent/CR20130401A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101905173B1 (ko) | 2018-11-28 |
| ZA201305780B (en) | 2014-04-30 |
| CR20130401A (es) | 2014-02-04 |
| AU2012207698A1 (en) | 2013-04-18 |
| BR112013018557A2 (pt) | 2016-11-22 |
| NZ588686A (en) | 2013-07-26 |
| CN103327984A (zh) | 2013-09-25 |
| IL227540A (en) | 2017-12-31 |
| KR20140012646A (ko) | 2014-02-03 |
| GT201300182A (es) | 2014-07-28 |
| WO2012099479A1 (en) | 2012-07-26 |
| IL227540A0 (en) | 2013-09-30 |
| BR112013018557B1 (pt) | 2021-11-03 |
| MX353876B (es) | 2018-02-01 |
| PE20140035A1 (es) | 2014-02-16 |
| CL2013002086A1 (es) | 2014-07-25 |
| CN103327984B (zh) | 2016-08-17 |
| CO6801732A2 (es) | 2013-11-29 |
| MX2013008407A (es) | 2013-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP18005828A (es) | Inhibidores de metalo-beta-lactamasa | |
| NI201300063A (es) | Método para el tratamiento de una infección | |
| CL2016002285A1 (es) | Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas | |
| CY1118250T1 (el) | Ορισμενες τριαζολοπυραζινες, συνθεσεις αυτων και μεθοδοι για τη χρηση αυτων | |
| CU24406B1 (es) | 1-{[(2s,3s,4s)-3-etil-4-fluoro-5-oxopirrolidin-2-il]metoxi}-7 -metoxiisoquinolin-6-carboxamida | |
| CL2014003035A1 (es) | Compuestos derivados de diazabiciclooctano, inhibidores de beta-lactamasa; composicion farmaceutica que los comprende; proceso para prepararlos; y metodo para tratar una infeccion bacteriana. | |
| EA201000775A1 (ru) | Ингибиторы бета-лактамазы | |
| BR112014000665A2 (pt) | composto, uso do mesmo, composição farmacêutica, agente antimicrobiano, e, método para previnir ou tratar uma infecção bacteriana | |
| CR11626A (es) | Inhibidores de beta-lactamasa | |
| CL2014000468A1 (es) | Compuestos derivados del acido 2-oxo-6-(fenil/heteroaril)l-1,2-dihidropiridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para el alivio de una infeccion bacteriana. | |
| CL2008001631A1 (es) | Compuestos derivados de heterociclos sustituidos, con la presencia de un grupo fenoxi, inhibidores de transcriptasa inversa; composicion farmaceutica; y uso en el tratamiento de infecciones virales por vih. | |
| CL2009000426A1 (es) | Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas | |
| CR20140428A (es) | Compuestos inhibidores de beta-lactamasas | |
| BR112016013509A2 (pt) | “sistema para a administração de inoculantes microbianos e materiais e métodos relacionados”. | |
| CL2011001180A1 (es) | Metodo y sistema para localizar y rastrear objetos en el ambiente de una mina que comprende definir areas, proporcionar y operar sistemas de radio para formar una pluralidad de redes y presentar visualmente las posiciones relativas de los diversos objetos dentro del area de operaciones en un sistema de pantalla. | |
| BR112017011478A2 (pt) | composto de conjugado anticorpo-antibiótico, conjugado anticorpo-antibiótico, composição farmacêutica, métodos de tratamento de uma infecção bacteriana e para exterminar staph aureus, processo para a preparação do composto, kit e intermediário antibiótico-ligante | |
| CO2019002246A2 (es) | Compuesto heterocíclico nitrogenado bicíclico | |
| AR105478A1 (es) | Grados líquidos y sólidos fundibles de peróxidos protegidos por quemadura | |
| AR085512A1 (es) | Composiciones desespumantes y procedimientos para aplicaciones de cementacion | |
| CL2019003051A1 (es) | Sistema para gestionar uno o más dispositivos fotovoltaicos. (divisional solicitud 201800393) | |
| CY1120016T1 (el) | Φαρμακοτεχνικες μορφες οξικης κασποφουνγκινης | |
| EP3689333A4 (en) | LOCAL INJECTION SOLUTION WITH TWO MEDICINAL PRODUCTS FOR SUBMUCOSAL INJECTION | |
| MX2020003665A (es) | Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo. | |
| WO2015024016A3 (en) | 2-piperidinyl substituted n,3-dihydroxybutanamides | |
| CL2012003202A1 (es) | Metodo para tratar una infeccion gastrointestinal recurrente de clostridium difficile, que comprende la administracion de fidaxomicina y donde el sujeto ha sido sometido a un tratamiento previo para combatir dicha infeccion. |